A comprehensive analysis of all-cause and cause-specific excess deaths in 30 countries during 2020
A comprehensive analysis of all-cause and cause-specific excess deaths in 30 countries during 2020
The impact of COVID-19 on mortality from specific causes of death remains poorly understood. This study analysed cause-of-death data provided by the World Health Organization from 2011 to 2019 to estimate excess deaths in 2020 in 30 countries. Over-dispersed Poisson regression models were used to estimate the number of deaths that would have been expected if the pandemic had not occurred, separately for men and women. The models included year and age categories to account for temporal trends and changes in size and age structure of the populations. Excess deaths were calculated by subtracting observed deaths from expected ones. Our analysis revealed significant excess deaths from ischemic heart diseases (IHD) (in 10 countries), cerebrovascular diseases (CVD) (in 10 countries), and diabetes (in 19 countries). The majority of countries experienced excess mortality greater than 10%, including Mexico (+ 38·8% for IHD, + 34·9% for diabetes), Guatemala (+ 30·0% for IHD, + 10·2% for CVD, + 39·7% for diabetes), Cuba (+ 18·8% for diabetes), Brazil (+ 12·9% for diabetes), the USA (+ 15·1% for diabetes), Slovenia (+ 33·8% for diabetes), Poland (+ 30·2% for IHD, + 19·5% for CVD, + 26 1% for diabetes), Estonia (+ 26·9% for CVD, + 34·7% for diabetes), Bulgaria (+ 22·8% for IHD, + 11·4% for diabetes), Spain (+ 19·7% for diabetes), Italy (+ 18·0% for diabetes), Lithuania (+ 17·6% for diabetes), Finland (+ 13·2% for diabetes) and Georgia (+ 10·7% for IHD, + 19·0% for diabetes). In 2020, 22 out of 30 countries had a significant increase in total mortality. Some of this excess was attributed to COVID-19, but a substantial increase was also observed in deaths attributed to cardiovascular diseases and diabetes.
COVID-19, Cardiovascular diseases, Diabetes, Excess deaths, Mortality, SARS-CoV-2
1153-1164
Alicandro, Gianfranco
035cde0b-0b40-48cd-921a-44ecd82039bb
Vecchia, Carlo La
2712dd2f-1f71-4cb8-ad8f-03f5b75187a2
Islam, Nazrul
e5345196-7479-438f-b4f6-c372d2135586
Pizzato, Margherita
89143166-4c2e-41b7-8140-7d046dfcb342
November 2023
Alicandro, Gianfranco
035cde0b-0b40-48cd-921a-44ecd82039bb
Vecchia, Carlo La
2712dd2f-1f71-4cb8-ad8f-03f5b75187a2
Islam, Nazrul
e5345196-7479-438f-b4f6-c372d2135586
Pizzato, Margherita
89143166-4c2e-41b7-8140-7d046dfcb342
Alicandro, Gianfranco, Vecchia, Carlo La, Islam, Nazrul and Pizzato, Margherita
(2023)
A comprehensive analysis of all-cause and cause-specific excess deaths in 30 countries during 2020.
European Journal of Epidemiology, 38 (11), .
(doi:10.1007/S10654-023-01044-X).
Abstract
The impact of COVID-19 on mortality from specific causes of death remains poorly understood. This study analysed cause-of-death data provided by the World Health Organization from 2011 to 2019 to estimate excess deaths in 2020 in 30 countries. Over-dispersed Poisson regression models were used to estimate the number of deaths that would have been expected if the pandemic had not occurred, separately for men and women. The models included year and age categories to account for temporal trends and changes in size and age structure of the populations. Excess deaths were calculated by subtracting observed deaths from expected ones. Our analysis revealed significant excess deaths from ischemic heart diseases (IHD) (in 10 countries), cerebrovascular diseases (CVD) (in 10 countries), and diabetes (in 19 countries). The majority of countries experienced excess mortality greater than 10%, including Mexico (+ 38·8% for IHD, + 34·9% for diabetes), Guatemala (+ 30·0% for IHD, + 10·2% for CVD, + 39·7% for diabetes), Cuba (+ 18·8% for diabetes), Brazil (+ 12·9% for diabetes), the USA (+ 15·1% for diabetes), Slovenia (+ 33·8% for diabetes), Poland (+ 30·2% for IHD, + 19·5% for CVD, + 26 1% for diabetes), Estonia (+ 26·9% for CVD, + 34·7% for diabetes), Bulgaria (+ 22·8% for IHD, + 11·4% for diabetes), Spain (+ 19·7% for diabetes), Italy (+ 18·0% for diabetes), Lithuania (+ 17·6% for diabetes), Finland (+ 13·2% for diabetes) and Georgia (+ 10·7% for IHD, + 19·0% for diabetes). In 2020, 22 out of 30 countries had a significant increase in total mortality. Some of this excess was attributed to COVID-19, but a substantial increase was also observed in deaths attributed to cardiovascular diseases and diabetes.
Text
s10654-023-01044-x
- Version of Record
More information
Accepted/In Press date: 12 August 2023
e-pub ahead of print date: 8 September 2023
Published date: November 2023
Additional Information:
Funding Information:
Open access funding provided by Università degli Studi di Milano within the CRUI-CARE Agreement. This research was supported by EU funding within the NextGeneration EU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases (Project no. PE00000007, INF-ACT).
Publisher Copyright:
© 2023, The Author(s).
Keywords:
COVID-19, Cardiovascular diseases, Diabetes, Excess deaths, Mortality, SARS-CoV-2
Identifiers
Local EPrints ID: 483306
URI: http://eprints.soton.ac.uk/id/eprint/483306
ISSN: 0393-2990
PURE UUID: 35f5e553-4afb-489f-a24c-37b0e4cf3808
Catalogue record
Date deposited: 27 Oct 2023 16:47
Last modified: 18 Mar 2024 04:07
Export record
Altmetrics
Contributors
Author:
Gianfranco Alicandro
Author:
Carlo La Vecchia
Author:
Nazrul Islam
Author:
Margherita Pizzato
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics